• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《乳腺癌临床实践指南(NCCN 指南)》第 4 版 2017 年版

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

出版信息

J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.

DOI:10.6004/jnccn.2018.0012
PMID:29523670
Abstract

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.

摘要

乳腺导管原位癌(DCIS)代表了乳腺导管中一组异质性的肿瘤病变。DCIS 的治疗目标是预防浸润性乳腺癌的发生。本文档重点介绍了 NCCN 指南专家组针对 DCIS 的检查、初始治疗、降低风险策略和监测的建议。

相似文献

1
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.《乳腺癌临床实践指南(NCCN 指南)》第 4 版 2017 年版
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.
2
Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.导管原位癌(DCIS)。一种极易治疗的乳腺癌。
Mayo Clin Womens Healthsource. 2009 Oct;13(10):1-2.
3
[Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group].[妇科肿瘤学工作组乳腺癌治疗指南。妇科肿瘤学工作组]
Gynakol Geburtshilfliche Rundsch. 1999;39(4):226-9. doi: 10.1159/000022317.
4
Avoiding Overtreatment of Ductal Carcinoma in situ.避免导管原位癌的过度治疗。
Trends Cancer. 2019 Jul;5(7):391-393. doi: 10.1016/j.trecan.2019.05.005. Epub 2019 Jun 20.
5
Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?导管原位癌局部治疗是否存在替代策略?
Surg Oncol Clin N Am. 2018 Jan;27(1):69-80. doi: 10.1016/j.soc.2017.08.002.
6
Is DCIS breast cancer, and how do I treat it?DCIS 是乳腺癌吗?我应该如何治疗?
Curr Treat Options Oncol. 2013 Mar;14(1):75-87. doi: 10.1007/s11864-012-0217-1.
7
ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS).ASO作者反思:导管原位癌(DCIS)的主动监测。
Ann Surg Oncol. 2020 Oct;27(11):4466-4467. doi: 10.1245/s10434-020-08637-w. Epub 2020 May 21.
8
Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.中东和北非地区乳腺癌 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S8-S15. doi: 10.6004/jnccn.2010.0126.
9
Advances and controversies in management of breast ductal carcinoma in situ (DCIS).乳腺导管原位癌(DCIS)治疗的进展与争议。
Eur J Surg Oncol. 2022 Apr;48(4):736-741. doi: 10.1016/j.ejso.2021.10.030. Epub 2021 Nov 9.
10
Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.乳腺导管原位癌:不断演变的观点
Cancer Treat Rev. 2000 Apr;26(2):103-25. doi: 10.1053/ctrv.1999.0149.

引用本文的文献

1
The value of percutaneous contrast-enhanced ultrasound in the detection and diagnosis of sentinel lymph nodes in breast cancer: comparison with pathological features.经皮超声造影在乳腺癌前哨淋巴结检测与诊断中的价值:与病理特征比较
Quant Imaging Med Surg. 2025 Sep 1;15(9):8309-8319. doi: 10.21037/qims-2024-2631. Epub 2025 Aug 14.
2
Case Report: Breast ductal carcinoma with microinvasion: a case tracked over 13 years.病例报告:乳腺导管癌伴微浸润:一例长达13年的追踪病例
Front Oncol. 2025 Aug 12;15:1560366. doi: 10.3389/fonc.2025.1560366. eCollection 2025.
3
Predictive value of shear wave elastography and molecular subtypes for postoperative efficacy in patients with early breast cancer.
剪切波弹性成像及分子亚型对早期乳腺癌患者术后疗效的预测价值
Ann Med. 2025 Dec;57(1):2544879. doi: 10.1080/07853890.2025.2544879. Epub 2025 Aug 18.
4
Associations of Molecular-Genetic Bioenergetics and Chemotherapy-Induced Fatigue Symptoms in Patients with Breast Cancer: A proposal development.乳腺癌患者分子遗传生物能量学与化疗所致疲劳症状的关联:一项提案制定
Nurs Healthc Int J. 2023;7(1). doi: 10.23880/nhij-16000278. Epub 2023 Jan 13.
5
An ultrasound-based model for predicting the response to neoadjuvant chemotherapy in early stage triple negative breast cancer patients.一种基于超声的模型,用于预测早期三阴性乳腺癌患者对新辅助化疗的反应。
BMC Med Imaging. 2025 Jul 8;25(1):275. doi: 10.1186/s12880-025-01818-7.
6
Intellectual or developmental disabilities and curative female breast cancer treatment: A population-based retrospective cohort study.智力或发育障碍与女性乳腺癌根治性治疗:一项基于人群的回顾性队列研究。
Breast. 2025 May 27;82:104509. doi: 10.1016/j.breast.2025.104509.
7
Multi-modal radiomics model based on four imaging modalities for predicting pathological complete response to neoadjuvant treatment in breast cancer.基于四种成像模态的多模态放射组学模型用于预测乳腺癌新辅助治疗的病理完全缓解
BMC Cancer. 2025 Jun 2;25(1):985. doi: 10.1186/s12885-025-14407-2.
8
Cancer treatment and survivorship statistics, 2025.2025年癌症治疗与生存统计数据
CA Cancer J Clin. 2025 Jul-Aug;75(4):308-340. doi: 10.3322/caac.70011. Epub 2025 May 30.
9
A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.一种用于预测乳腺癌新辅助化疗病理完全缓解的多模态全自动系统。
Sci Adv. 2025 May 2;11(18):eadr1576. doi: 10.1126/sciadv.adr1576. Epub 2025 Apr 30.
10
Dual-layer detector spectral computed tomography quantitative parameters for predicting pathological complete remission after neoadjuvant treatment of breast cancer.双层探测器光谱计算机断层扫描定量参数预测乳腺癌新辅助治疗后病理完全缓解情况
Quant Imaging Med Surg. 2025 Jan 2;15(1):149-163. doi: 10.21037/qims-24-511. Epub 2024 Dec 17.